Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Year-over-year book value per share growth
Latest
-1.67%
↓ 109% vs avg
Percentile
P50
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
18.65%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -1.67% |
| Q3 2025 | 70.44% |
| Q2 2025 | -25.43% |
| Q1 2025 | 67.81% |
| Q4 2024 | -19.51% |
| Q3 2024 | -19.08% |
| Q2 2024 | -19.55% |
| Q1 2024 | 21.47% |
| Q4 2023 | -9.03% |
| Q3 2023 | -7.77% |
| Q2 2023 | -40.00% |
| Q1 2023 | 219.09% |
| Q4 2022 | -19.73% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 100.00% |
| Q4 2021 | 0.00% |